DICLOFENAC SODIUM TOPICAL GEL, 1%

DICLOFENAC SODIUM TOPICAL GEL, 1% was reported 36342 times

DICLOFENAC SODIUM TOPICAL GEL, 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUPUS VULGARIS 899 0.7135
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 472 0.7066
2 SWOLLEN JOINT COUNT INCREASED 2089 0.6544
3 HEPATIC ENZYME 95 0.6376
4 RHEUMATIC FEVER 2842 0.6369
5 GRIP STRENGTH 145 0.6332
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1264 0.6311
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4083 0.5693
8 C-REACTIVE PROTEIN 520 0.5609
9 FACET JOINT SYNDROME 1707 0.5238
10 DUODENAL ULCER PERFORATION 3832 0.5148
11 RHEUMATOID FACTOR POSITIVE 2968 0.5133
12 SWOLLEN JOINT COUNT 128 0.5120
13 HYPOCHOLESTEROLAEMIA 171 0.4844
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 991 0.4778
15 PEMPHIGUS 5834 0.4662
16 DISLOCATION OF VERTEBRA 1009 0.4420
17 RETINITIS 761 0.4401
18 X-RAY ABNORMAL 745 0.4162
19 HAND DEFORMITY 5361 0.4083
20 HELICOBACTER INFECTION 3800 0.3694
21 SERONEGATIVE ARTHRITIS 374 0.3264
22 MUSCLE INJURY 2704 0.3260
23 PERIPHERAL VENOUS DISEASE 1331 0.3256
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 34 0.3238
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 178 0.3173
26 FOLLICULITIS 3219 0.3067
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1784 0.2744
28 PERICARDITIS 4585 0.2726
29 GLOSSODYNIA 5878 0.2623
30 SYNOVITIS 4715 0.2612
31 C-REACTIVE PROTEIN ABNORMAL 1639 0.2553
32 INSPIRATORY CAPACITY DECREASED 66 0.2383
33 PORPHYRIA ACUTE 337 0.2348
34 BREAST CANCER STAGE III 1429 0.2204
35 LYMPHATIC FISTULA 22 0.2200
36 BONE EROSION 717 0.2025
37 LIP DRY 1758 0.1934
38 WOUND 5277 0.1886
39 GRIP STRENGTH DECREASED 1615 0.1833
40 ANALGESIC DRUG LEVEL ABOVE THERAPEUTIC 26 0.1769
41 BURSITIS 2087 0.1718
42 SYSTEMIC LUPUS ERYTHEMATOSUS 6004 0.1690
43 EMBOLIA CUTIS MEDICAMENTOSA 127 0.1595
44 JOINT RANGE OF MOTION DECREASED 2135 0.1590
45 DRUG TOLERANCE DECREASED 445 0.1583
46 HYPERCHOLESTEROLAEMIA 1521 0.1574
47 WOUND INFECTION 1715 0.1564
48 ONYCHOMADESIS 649 0.1545
49 CONTRAINDICATED PRODUCT ADMINISTERED 4485 0.1480
50 LIVE BIRTH 1229 0.1468
51 IRRITABLE BOWEL SYNDROME 3022 0.1408
52 BLEPHAROSPASM 840 0.1333
53 AUTOIMMUNE DISORDER 1275 0.1307
54 MUSCULOSKELETAL DEFORMITY 30 0.1282
55 ONYCHOMYCOSIS 553 0.1259
56 TEMPERATURE REGULATION DISORDER 273 0.1224
57 LIVER INJURY 2937 0.1195
58 DEATH NEONATAL 166 0.1193
59 FIBROMYALGIA 2851 0.1172
60 OVERLAP SYNDROME 82 0.1171
61 FINGER DEFORMITY 564 0.1163
62 NAIL DISORDER 926 0.1057
63 RED BLOOD CELL SEDIMENTATION RATE 28 0.1004
64 JOINT DESTRUCTION 154 0.0990
65 TYPE 2 DIABETES MELLITUS 3307 0.0981
66 MATERNAL EXPOSURE TIMING UNSPECIFIED 363 0.0965
67 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 25 0.0965
68 ARTHROPATHY 5350 0.0962
69 IMPAIRED HEALING 3139 0.0955
70 NAIL OPERATION 39 0.0942
71 PRESCRIBED OVERDOSE 1799 0.0929
72 OBESITY 1435 0.0900
73 PRODUCT LABEL CONFUSION 523 0.0896
74 SCIATICA 1415 0.0887
75 PSORIATIC ARTHROPATHY 3533 0.0870
76 COELIAC DISEASE 847 0.0863
77 INTESTINAL DIAPHRAGM DISEASE 24 0.0860
78 EXOSTOSIS 782 0.0855
79 WRIST DEFORMITY 50 0.0813
80 COLONIC STENOSIS 27 0.0785
81 HIP ARTHROPLASTY 1170 0.0763
82 INFUSION RELATED REACTION 5042 0.0760
83 LUPUS-LIKE SYNDROME 682 0.0751
84 RED BLOOD CELL SEDIMENTATION RATE INCREASED 805 0.0727
85 PULMONARY FIBROSIS 1394 0.0726
86 LOWER LIMB FRACTURE 1379 0.0717
87 WALKING AID USER 470 0.0712
88 HEPATIC ENZYME INCREASED 4812 0.0705
89 DISCOMFORT 4256 0.0697
90 BLOOD CHOLESTEROL INCREASED 3185 0.0683
91 BACK INJURY 719 0.0660
92 DUCTUS ARTERIOSUS STENOSIS FOETAL 27 0.0634
93 BREAST CANCER STAGE II 526 0.0632
94 FOOT DEFORMITY 688 0.0620
95 THERAPEUTIC PRODUCT EFFECT DECREASED 2764 0.0616
96 SPONDYLITIS 222 0.0610
97 LOWER RESPIRATORY TRACT INFECTION 2774 0.0609
98 BLISTER 3331 0.0593
99 SWELLING 5551 0.0593
100 GAIT INABILITY 1967 0.0588
101 ULCER HAEMORRHAGE 395 0.0583
102 RHEUMATOID ARTHRITIS 6539 0.0575
103 JOINT DISLOCATION 606 0.0573
104 INFUSION SITE REACTION 171 0.0572
105 EYE INJURY 173 0.0569
106 FOETAL DEATH 291 0.0561
107 PRESCRIBED UNDERDOSE 1096 0.0549
108 KNEE ARTHROPLASTY 1135 0.0539
109 PUSTULAR PSORIASIS 180 0.0524
110 FOOD ALLERGY 399 0.0516
111 OSTEOARTHRITIS 2153 0.0507
112 MATERNAL EXPOSURE DURING PREGNANCY 4431 0.0497
113 NIGHT SWEATS 1596 0.0495
114 CONGENITAL ANOMALY 372 0.0480
115 PERFUME SENSITIVITY 27 0.0475
116 DRUG INTOLERANCE 4532 0.0469
117 STOMATITIS 2843 0.0468
118 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 107 0.0464
119 JOINT SWELLING 5390 0.0446
120 MOBILITY DECREASED 3089 0.0429
121 WHEEZING 2542 0.0428
122 TREATMENT FAILURE 3464 0.0418
123 C-REACTIVE PROTEIN INCREASED 1521 0.0418
124 LIVER FUNCTION TEST INCREASED 882 0.0410
125 DRUG TOLERANCE 207 0.0409
126 INJURY 2873 0.0408
127 BLOODY DISCHARGE 46 0.0402
128 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 733 0.0400
129 MUSCULOSKELETAL STIFFNESS 3499 0.0399
130 DEAFNESS TRANSITORY 34 0.0398
131 GASTROINTESTINAL EROSION 25 0.0393
132 HEPATIC CIRRHOSIS 734 0.0390
133 EXPOSURE DURING PREGNANCY 2381 0.0383
134 MEAN PLATELET VOLUME DECREASED 32 0.0381
135 ILL-DEFINED DISORDER 2279 0.0375
136 TASTE DISORDER 759 0.0374
137 INFLAMMATION 1922 0.0372
138 ROAD TRAFFIC ACCIDENT 1542 0.0368
139 ABDOMINAL DISCOMFORT 6157 0.0367
140 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 626 0.0365
141 NORMAL NEWBORN 196 0.0360
142 SPINAL FUSION SURGERY 146 0.0360
143 IMMUNODEFICIENCY 536 0.0359
144 RASH VESICULAR 170 0.0351
145 ADVERSE REACTION 462 0.0348
146 VASCULAR ACCESS COMPLICATION 28 0.0346
147 LUNG DISORDER 1686 0.0344
148 OEDEMA 1861 0.0343
149 GENERAL PHYSICAL HEALTH DETERIORATION 3917 0.0338
150 MUSCULOSKELETAL PAIN 1722 0.0328
151 LIVER DISORDER 1397 0.0315
152 DELIRIUM 1078 0.0310
153 SLEEP DISORDER 2192 0.0310
154 INTENTIONAL PRODUCT USE ISSUE 2674 0.0305
155 GASTRIC ULCER PERFORATION 38 0.0300
156 ALOPECIA 5891 0.0300
157 GASTROINTESTINAL DISORDER 2649 0.0295
158 PRODUCT USED FOR UNKNOWN INDICATION 37 0.0294
159 RHEUMATOID LUNG 28 0.0293
160 PREGNANCY 576 0.0287
161 DRUG-INDUCED LIVER INJURY 902 0.0287
162 EPILEPSY 854 0.0279
163 JOINT STIFFNESS 725 0.0276
164 POLYARTHRITIS 144 0.0273
165 HYPERSENSITIVITY 4992 0.0269
166 DRY MOUTH 2047 0.0252
167 CONTUSION 2410 0.0250
168 THERAPY NON-RESPONDER 1110 0.0247
169 SINUSITIS 2457 0.0239
170 EAR INFECTION 634 0.0238
171 MEAN CELL VOLUME DECREASED 35 0.0227
172 DISABILITY 448 0.0226
173 EAR PAIN 438 0.0225
174 HEPATITIS 572 0.0223
175 PRODUCT USE ISSUE 4200 0.0223
176 INFECTION 3150 0.0217
177 MYOSITIS 187 0.0208
178 GENERAL SYMPTOM 156 0.0208
179 INTERNATIONAL NORMALISED RATIO FLUCTUATION 43 0.0208
180 HYPOAESTHESIA 3100 0.0207
181 KOUNIS SYNDROME 47 0.0207
182 OSTEOPOROSIS 836 0.0203
183 DYSPEPSIA 1999 0.0203
184 ARTERIAL HAEMORRHAGE 23 0.0201
185 REFLUX GASTRITIS 24 0.0199
186 PERIPHERAL SWELLING 3024 0.0196
187 CONFUSIONAL STATE 3111 0.0192
188 SEROMA 24 0.0189
189 HYPERTENSION 3986 0.0188
190 UPPER RESPIRATORY TRACT INFECTION 855 0.0185
191 MIGRAINE 1737 0.0182
192 MEAN CELL HAEMOGLOBIN DECREASED 33 0.0180
193 NECK PAIN 991 0.0177
194 SACROILIITIS 33 0.0175
195 ANKYLOSING SPONDYLITIS 225 0.0171
196 SUSPECTED OFF LABEL USE 77 0.0170
197 NASOPHARYNGITIS 3135 0.0170
198 LARGE INTESTINAL ULCER 46 0.0169
199 ASTHMA 1850 0.0164
200 DUODENAL ULCER 115 0.0163
201 AMNESIA 1036 0.0159
202 GASTROOESOPHAGEAL REFLUX DISEASE 1274 0.0158
203 PEPTIC ULCER 52 0.0157
204 URTICARIA 2620 0.0156
205 INFLAMMATORY MARKER INCREASED 77 0.0155
206 FREQUENT BOWEL MOVEMENTS 416 0.0154
207 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 259 0.0152
208 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 715 0.0149
209 WEIGHT FLUCTUATION 154 0.0147
210 BACK DISORDER 238 0.0146
211 LYME DISEASE 48 0.0144
212 RASH 6250 0.0143
213 FIBROSIS 44 0.0143
214 WEIGHT INCREASED 3192 0.0142
215 RESPIRATORY DISORDER 426 0.0142
216 CONDITION AGGRAVATED 4313 0.0142
217 ADVERSE EVENT 1268 0.0137
218 MUSCULAR WEAKNESS 1546 0.0136
219 MEMORY IMPAIRMENT 1820 0.0132
220 LIPOMA 34 0.0131
221 SPINAL STENOSIS 54 0.0131
222 MEDICATION ERROR 722 0.0130
223 VITAMIN B12 DECREASED 37 0.0128
224 PAIN 7594 0.0124
225 FOOT OPERATION 61 0.0123
226 ARTHRITIS 967 0.0123
227 JOINT ARTHROPLASTY 22 0.0123
228 ABDOMINAL PAIN UPPER 2520 0.0122
229 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 868 0.0122
230 ADVERSE DRUG REACTION 1088 0.0121
231 IRON DEFICIENCY 54 0.0120
232 ARTHRALGIA 4992 0.0120
233 CHRONIC GASTRITIS 27 0.0119
234 MELAENA 262 0.0119
235 FLUID RETENTION 605 0.0119
236 GASTRIC ULCER 226 0.0119
237 ADRENAL INSUFFICIENCY 140 0.0115
238 MUSCLE SPASTICITY 139 0.0113
239 DECREASED APPETITE 2624 0.0113
240 MICROCYTIC ANAEMIA 23 0.0110
241 SYNOVIAL CYST 51 0.0110
242 FUNCTIONAL GASTROINTESTINAL DISORDER 38 0.0110
243 PRODUCT USE IN UNAPPROVED INDICATION 2694 0.0109
244 OEDEMA PERIPHERAL 1324 0.0109
245 DUODENAL ULCER HAEMORRHAGE 31 0.0108
246 GASTROINTESTINAL ULCER 24 0.0108
247 NEPHROGENIC ANAEMIA 50 0.0108
248 PARAESTHESIA 1698 0.0108
249 AORTIC ARTERIOSCLEROSIS 27 0.0105
250 CHEST PAIN 1927 0.0104
251 GASTRITIS EROSIVE 48 0.0103
252 GASTRIC PERFORATION 28 0.0103
253 MONOCYTE COUNT INCREASED 37 0.0102
254 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 27 0.0101
255 MUSCLE SPASMS 1844 0.0100
256 SHOULDER ARTHROPLASTY 27 0.0100
257 HYPERPARATHYROIDISM SECONDARY 25 0.0100
258 LUMBAR SPINAL STENOSIS 29 0.0099
259 DIVERTICULUM INTESTINAL 43 0.0098
260 DUODENITIS 30 0.0098
261 RASH ERYTHEMATOUS 465 0.0097
262 WHITE BLOOD CELL COUNT INCREASED 369 0.0096
263 UNDERDOSE 696 0.0095
264 ULCERATIVE KERATITIS 26 0.0095
265 INCORRECT PRODUCT ADMINISTRATION DURATION 205 0.0095
266 PYREXIA 3237 0.0093
267 RECTAL HAEMORRHAGE 401 0.0093
268 PLATELET COUNT INCREASED 121 0.0093
269 FATIGUE 7165 0.0092
270 HYPERTRANSAMINASAEMIA 64 0.0092
271 JOINT EFFUSION 63 0.0091
272 GAIT DISTURBANCE 1746 0.0091
273 DECREASED IMMUNE RESPONSIVENESS 89 0.0091
274 PAIN IN EXTREMITY 2648 0.0090
275 UPPER GASTROINTESTINAL HAEMORRHAGE 149 0.0088
276 PHYSICAL DISABILITY 39 0.0088
277 TENDERNESS 91 0.0087
278 DEPRESSION 1979 0.0087
279 OLIGOHYDRAMNIOS 29 0.0087
280 HEPATIC CYST 29 0.0085
281 PRODUCT ADMINISTRATION INTERRUPTED 67 0.0085
282 TYPE I HYPERSENSITIVITY 30 0.0085
283 NECROTISING FASCIITIS 30 0.0085
284 INSOMNIA 2258 0.0085
285 MIGRAINE WITH AURA 23 0.0085
286 TYPE IV HYPERSENSITIVITY REACTION 23 0.0084
287 PRE-EXISTING CONDITION IMPROVED 52 0.0083
288 FEELING HOT 508 0.0083
289 SEDATION 217 0.0083
290 KERATITIS 25 0.0082
291 PSORIASIS 1074 0.0082
292 MATERNAL EXPOSURE BEFORE PREGNANCY 55 0.0080
293 COLITIS ULCERATIVE 359 0.0080
294 ABDOMINAL DISTENSION 835 0.0080
295 LABORATORY TEST ABNORMAL 232 0.0079
296 ELECTRIC SHOCK SENSATION 22 0.0079
297 VOMITING 3687 0.0078
298 PRURITUS 2965 0.0077
299 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0077
300 WOUND DEHISCENCE 26 0.0077
301 INJECTION SITE REACTION 529 0.0077
302 SUDDEN CARDIAC DEATH 26 0.0076
303 REBOUND ACID HYPERSECRETION 23 0.0076
304 NODULE 99 0.0076
305 PNEUMONIA 2431 0.0075
306 CREPITATIONS 22 0.0074
307 THERAPEUTIC RESPONSE DECREASED 447 0.0074
308 IRON DEFICIENCY ANAEMIA 67 0.0073
309 GASTRIC ULCER HAEMORRHAGE 40 0.0072
310 TENDON DISORDER 47 0.0072
311 LARGE INTESTINE PERFORATION 50 0.0072
312 BRONCHITIS 532 0.0072
313 MALAISE 3149 0.0072
314 HEADACHE 4468 0.0071
315 ARTHRITIS BACTERIAL 29 0.0071
316 HEPATIC PAIN 30 0.0070
317 HAEMATEMESIS 177 0.0070
318 VISUAL IMPAIRMENT 865 0.0070
319 ABDOMINAL TENDERNESS 34 0.0068
320 ESCHERICHIA INFECTION 56 0.0068
321 TRICUSPID VALVE INCOMPETENCE 54 0.0068
322 OFF LABEL USE 5937 0.0068
323 ANTINUCLEAR ANTIBODY POSITIVE 22 0.0068
324 PANCREATITIS 356 0.0067
325 NIGHTMARE 231 0.0067
326 ASTHENIA 2501 0.0066
327 INTENTIONAL PRODUCT MISUSE 579 0.0066
328 OLIGURIA 41 0.0066
329 TOXIC EPIDERMAL NECROLYSIS 100 0.0066
330 NEONATAL RESPIRATORY DISTRESS SYNDROME 23 0.0065
331 SPINAL OSTEOARTHRITIS 57 0.0065
332 FAECALOMA 35 0.0064
333 ABDOMINAL PAIN 1485 0.0064
334 PARANASAL SINUS DISCOMFORT 24 0.0063
335 BODY TEMPERATURE INCREASED 129 0.0063
336 DIZZINESS 3118 0.0062
337 SEASONAL ALLERGY 88 0.0062
338 TACHYCARDIA 552 0.0062
339 BLOOD UREA INCREASED 104 0.0062
340 HYPERHIDROSIS 795 0.0062
341 OVERWEIGHT 33 0.0061
342 GASTROENTERITIS VIRAL 109 0.0060
343 ANAPHYLACTIC REACTION 330 0.0060
344 PERIORBITAL OEDEMA 31 0.0060
345 DRUG INEFFECTIVE 7846 0.0059
346 DYSPNOEA 3368 0.0059
347 POSTOPERATIVE WOUND INFECTION 40 0.0059
348 NEPHROLITHIASIS 267 0.0058
349 RENAL FAILURE ACUTE 247 0.0058
350 HUMERUS FRACTURE 28 0.0058
351 DRUG EFFECT LESS THAN EXPECTED 86 0.0058
352 SKIN NECROSIS 30 0.0058
353 PRODUCT PHYSICAL CONSISTENCY ISSUE 32 0.0058
354 DYSLIPIDAEMIA 29 0.0057
355 PRODUCT QUALITY ISSUE 771 0.0057
356 DIABETIC NEUROPATHY 28 0.0056
357 GASTRIC HAEMORRHAGE 65 0.0056
358 WHEELCHAIR USER 25 0.0056
359 MOVEMENT DISORDER 180 0.0056
360 ANXIETY 1594 0.0056
361 ABNORMAL LOSS OF WEIGHT 38 0.0056
362 MUSCULOSKELETAL CHEST PAIN 86 0.0056
363 GASTROINTESTINAL PAIN 61 0.0055
364 THROMBOCYTOPENIA 620 0.0055
365 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 162 0.0055
366 SECRETION DISCHARGE 69 0.0055
367 SPINAL COLUMN STENOSIS 26 0.0055
368 SPINAL DISORDER 52 0.0055
369 PANCREATIC DISORDER 27 0.0055
370 DIARRHOEA 3534 0.0055
371 PHLEBITIS 28 0.0055
372 RHINITIS ALLERGIC 24 0.0054
373 APPLICATION SITE RASH 74 0.0054
374 HEAD DISCOMFORT 95 0.0054
375 WEIGHT DECREASED 1497 0.0054
376 BACK PAIN 1245 0.0054
377 DERMATITIS ALLERGIC 67 0.0053
378 RENAL TUBULAR NECROSIS 52 0.0053
379 IMMUNE THROMBOCYTOPENIA 24 0.0052
380 PHARYNGITIS 65 0.0052
381 COMPRESSION FRACTURE 28 0.0052
382 SPINAL PAIN 60 0.0051
383 ASPIRATION 56 0.0051
384 ANURIA 44 0.0051
385 BREAST CANCER STAGE I 47 0.0051
386 MULTIPLE DRUG OVERDOSE 25 0.0050
387 RENAL CYST 40 0.0050
388 HIATUS HERNIA 65 0.0050
389 HYPOCALCAEMIA 95 0.0050
390 LUMBAR VERTEBRAL FRACTURE 23 0.0050
391 FOETAL EXPOSURE DURING PREGNANCY 407 0.0050
392 LOWER GASTROINTESTINAL HAEMORRHAGE 37 0.0050
393 GUILLAIN-BARRE SYNDROME 24 0.0050
394 RENAL FUNCTION TEST ABNORMAL 23 0.0049
395 DEFORMITY 46 0.0049
396 GROIN PAIN 43 0.0049
397 NERVE COMPRESSION 45 0.0049
398 SLEEP APNOEA SYNDROME 93 0.0049
399 NAUSEA 3851 0.0049
400 INTERVERTEBRAL DISC DEGENERATION 45 0.0049
401 PURPURA 43 0.0049
402 PHARYNGEAL SWELLING 47 0.0048
403 VITAMIN D DEFICIENCY 46 0.0047
404 MUSCULOSKELETAL DISCOMFORT 81 0.0047
405 URINE OUTPUT DECREASED 41 0.0047
406 ENDOPHTHALMITIS 28 0.0047
407 HAEMODIALYSIS 39 0.0046
408 LEUKOCYTOSIS 84 0.0046
409 HYPOKALAEMIA 214 0.0046
410 LIMB DISCOMFORT 143 0.0046
411 ANAPHYLACTIC SHOCK 119 0.0046
412 MATERNAL DRUGS AFFECTING FOETUS 35 0.0046
413 CHRONIC KIDNEY DISEASE 345 0.0045
414 ENTEROCOLITIS 26 0.0045
415 END STAGE RENAL DISEASE 82 0.0045
416 PRODUCT DELIVERY MECHANISM ISSUE 24 0.0045
417 ANKLE FRACTURE 69 0.0045
418 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
419 BLOOD ALBUMIN DECREASED 35 0.0044
420 APLASTIC ANAEMIA 23 0.0044
421 MULTI-ORGAN FAILURE 76 0.0044
422 GASTROINTESTINAL HAEMORRHAGE 367 0.0044
423 ECCHYMOSIS 30 0.0044
424 SPINAL COMPRESSION FRACTURE 36 0.0043
425 SKIN LESION 119 0.0043
426 FAECES DISCOLOURED 94 0.0043
427 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
428 TUBULOINTERSTITIAL NEPHRITIS 81 0.0043
429 NEURALGIA 105 0.0043
430 NECROSIS 24 0.0043
431 INFUSION SITE SWELLING 27 0.0043
432 RASH PRURITIC 232 0.0043
433 MITRAL VALVE INCOMPETENCE 48 0.0042
434 ARTERIOSCLEROSIS CORONARY ARTERY 28 0.0042
435 HYPERKALAEMIA 147 0.0042
436 FOOT FRACTURE 79 0.0042
437 CONCUSSION 32 0.0041
438 TOOTH ABSCESS 42 0.0041
439 FALL 1364 0.0041
440 HEPATIC STEATOSIS 76 0.0041
441 INTERVERTEBRAL DISC PROTRUSION 89 0.0041
442 PREMATURE LABOUR 23 0.0041
443 IMPAIRED GASTRIC EMPTYING 55 0.0040
444 INFUSION SITE ERYTHEMA 34 0.0040
445 RESPIRATORY TRACT INFECTION 105 0.0040
446 APPLICATION SITE VESICLES 26 0.0040
447 NASAL DRYNESS 25 0.0040
448 HAEMATOCRIT DECREASED 79 0.0040
449 TACHYPNOEA 54 0.0040
450 ULCER 63 0.0040
451 LEUKOPENIA 198 0.0040
452 BLOOD ALKALINE PHOSPHATASE INCREASED 98 0.0039
453 PULMONARY CONGESTION 52 0.0039
454 RESPIRATORY RATE INCREASED 35 0.0039
455 CIRCULATORY COLLAPSE 67 0.0039
456 SHOCK HAEMORRHAGIC 32 0.0039
457 PERITONITIS 81 0.0039
458 DISSEMINATED INTRAVASCULAR COAGULATION 55 0.0039
459 HYPERAESTHESIA 32 0.0039
460 OSTEOPENIA 59 0.0039
461 SCOLIOSIS 24 0.0039
462 LIMB INJURY 105 0.0039
463 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 212 0.0039
464 NEPHROPATHY 36 0.0039
465 COLITIS ISCHAEMIC 26 0.0039
466 SKIN HAEMORRHAGE 57 0.0038
467 FEEDING DISORDER 78 0.0038
468 PROTHROMBIN TIME PROLONGED 23 0.0038
469 JOINT INJURY 82 0.0038
470 BLOOD SODIUM DECREASED 72 0.0038
471 BLOOD URIC ACID INCREASED 22 0.0038
472 GASTRITIS 100 0.0038
473 DIVERTICULUM 27 0.0038
474 CHOLECYSTITIS 45 0.0038
475 DERMATITIS CONTACT 43 0.0038
476 UVEITIS 51 0.0038
477 ERYTHEMA MULTIFORME 35 0.0037
478 ROTATOR CUFF SYNDROME 48 0.0037
479 STAPHYLOCOCCAL INFECTION 123 0.0037
480 ATELECTASIS 36 0.0037
481 DRUG ERUPTION 66 0.0037
482 BLOOD LACTATE DEHYDROGENASE INCREASED 59 0.0037
483 PAIN IN JAW 105 0.0037
484 EYE PAIN 209 0.0037
485 GAMMA-GLUTAMYLTRANSFERASE INCREASED 82 0.0037
486 POST PROCEDURAL INFECTION 30 0.0037
487 DYSSTASIA 107 0.0037
488 NEPHROTIC SYNDROME 25 0.0036
489 CARPAL TUNNEL SYNDROME 51 0.0036
490 APPLICATION SITE PAIN 80 0.0036
491 ANGIOEDEMA 160 0.0036
492 SNEEZING 81 0.0036
493 MOUTH ULCERATION 76 0.0036
494 INFUSION SITE PAIN 46 0.0036
495 EATING DISORDER 76 0.0036
496 PERIPHERAL COLDNESS 49 0.0036
497 RETCHING 76 0.0036
498 LIGAMENT SPRAIN 35 0.0035
499 FLANK PAIN 33 0.0035
500 ARTERIOSCLEROSIS 33 0.0035
501 HAEMOGLOBIN DECREASED 357 0.0035
502 BLOOD MAGNESIUM DECREASED 30 0.0035
503 FACIAL PAIN 31 0.0035
504 OVERDOSE 748 0.0035
505 DECUBITUS ULCER 28 0.0034
506 AFFECTIVE DISORDER 27 0.0034
507 RED BLOOD CELL COUNT DECREASED 98 0.0034
508 MYOCARDIAL ISCHAEMIA 39 0.0034
509 GASTROENTERITIS 50 0.0034
510 INITIAL INSOMNIA 35 0.0034
511 DRUG INTERACTION 541 0.0034
512 JAUNDICE 91 0.0034
513 SENSORY DISTURBANCE 54 0.0034
514 HYPERLIPIDAEMIA 40 0.0033
515 SKIN REACTION 47 0.0033
516 BLOOD PRESSURE SYSTOLIC INCREASED 65 0.0033
517 MICTURITION URGENCY 38 0.0033
518 VISUAL FIELD DEFECT 24 0.0033
519 OSTEOMYELITIS 60 0.0033
520 SUDDEN DEATH 35 0.0033
521 ECONOMIC PROBLEM 50 0.0033
522 POLYURIA 27 0.0033
523 POST-TRAUMATIC STRESS DISORDER 22 0.0033
524 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
525 SWOLLEN TONGUE 102 0.0033
526 TOOTH FRACTURE 36 0.0033
527 PULMONARY HYPERTENSION 68 0.0033
528 METABOLIC ACIDOSIS 104 0.0032
529 RESTLESS LEGS SYNDROME 59 0.0032
530 SEPTIC SHOCK 141 0.0032
531 TENDON RUPTURE 40 0.0032
532 STEVENS-JOHNSON SYNDROME 72 0.0032
533 HYPOALBUMINAEMIA 25 0.0032
534 HEPATIC FUNCTION ABNORMAL 120 0.0032
535 PHOTOPHOBIA 60 0.0032
536 ANOREXIA 41 0.0032
537 URINARY RETENTION 106 0.0032
538 SHOCK 73 0.0032
539 CHOLELITHIASIS 104 0.0032
540 FAECES SOFT 23 0.0032
541 FACE OEDEMA 53 0.0031
542 CORONARY ARTERY DISEASE 95 0.0031
543 HAEMARTHROSIS 28 0.0031
544 ACUTE KIDNEY INJURY 475 0.0031
545 DIARRHOEA HAEMORRHAGIC 29 0.0031
546 BODY HEIGHT DECREASED 33 0.0031
547 BRONCHOSPASM 44 0.0031
548 LOSS OF CONSCIOUSNESS 395 0.0031
549 BRAIN FOG 48 0.0031
550 MULTIPLE ALLERGIES 24 0.0031
551 UPPER-AIRWAY COUGH SYNDROME 25 0.0030
552 BLOOD IRON DECREASED 36 0.0030
553 BLOOD CREATININE INCREASED 198 0.0030
554 ERYTHEMA 621 0.0030
555 RIB FRACTURE 62 0.0030
556 ORAL CANDIDIASIS 39 0.0030
557 PRODUCT ODOUR ABNORMAL 31 0.0030
558 KIDNEY INFECTION 58 0.0030
559 BLOOD URINE PRESENT 56 0.0029
560 ERUCTATION 57 0.0029
561 SKIN INFECTION 33 0.0029
562 PLEURAL EFFUSION 179 0.0029
563 INCONTINENCE 31 0.0029
564 ELECTROCARDIOGRAM ABNORMAL 23 0.0029
565 BLOOD POTASSIUM INCREASED 47 0.0029
566 TREATMENT NONCOMPLIANCE 157 0.0029
567 DEAFNESS 75 0.0029
568 METASTASES TO BONE 47 0.0029
569 RENAL IMPAIRMENT 240 0.0029
570 IMPAIRED WORK ABILITY 61 0.0029
571 LOCALISED INFECTION 69 0.0029
572 DYSPNOEA EXERTIONAL 107 0.0028
573 MIDDLE INSOMNIA 53 0.0028
574 OESOPHAGITIS 31 0.0028
575 MUSCULOSKELETAL DISORDER 54 0.0028
576 CONSTIPATION 618 0.0028
577 NEUTROPHIL COUNT INCREASED 29 0.0028
578 RENAL FAILURE 376 0.0028
579 PROSTATIC SPECIFIC ANTIGEN INCREASED 39 0.0028
580 PRODUCTIVE COUGH 135 0.0028
581 GENERALISED OEDEMA 35 0.0028
582 LIP SWELLING 94 0.0028
583 BONE DISORDER 51 0.0028
584 GASTROINTESTINAL INFECTION 25 0.0028
585 ASPARTATE AMINOTRANSFERASE INCREASED 148 0.0028
586 SKIN LACERATION 30 0.0028
587 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
588 SKIN ULCER 71 0.0027
589 ATRIAL SEPTAL DEFECT 23 0.0027
590 HAEMATOCHEZIA 151 0.0027
591 HYPONATRAEMIA 154 0.0027
592 SPLENOMEGALY 32 0.0027
593 TRANSIENT ISCHAEMIC ATTACK 92 0.0027
594 GASTRIC DISORDER 93 0.0027
595 ACUTE HEPATIC FAILURE 37 0.0027
596 CHROMATURIA 61 0.0027
597 VENTRICULAR EXTRASYSTOLES 28 0.0027
598 RENAL INJURY 80 0.0027
599 SCAR 46 0.0027
600 PALLOR 73 0.0027
601 BLOOD PRESSURE DECREASED 178 0.0027
602 SINUS CONGESTION 36 0.0027
603 HYPOPHAGIA 68 0.0027
604 ILEUS 33 0.0027
605 HEPATOMEGALY 26 0.0026
606 RENAL PAIN 28 0.0026
607 CYSTITIS 84 0.0026
608 RASH PAPULAR 59 0.0026
609 ILLNESS 271 0.0026
610 SCAB 30 0.0026
611 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 474 0.0026
612 DYSURIA 96 0.0026
613 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
614 POOR QUALITY SLEEP 56 0.0026
615 ALANINE AMINOTRANSFERASE INCREASED 159 0.0026
616 DRUG EXPOSURE DURING PREGNANCY 88 0.0026
617 NASAL CONGESTION 152 0.0026
618 HOSPITALISATION 397 0.0026
619 NEPHROPATHY TOXIC 29 0.0026
620 BIPOLAR DISORDER 28 0.0026
621 GOUT 46 0.0026
622 DRY THROAT 26 0.0026
623 NOCTURIA 31 0.0026
624 DISORIENTATION 101 0.0025
625 BLOOD PRESSURE INCREASED 389 0.0025
626 CARDIAC MURMUR 22 0.0025
627 BODY TEMPERATURE DECREASED 25 0.0025
628 QUALITY OF LIFE DECREASED 34 0.0025
629 ABDOMINAL PAIN LOWER 64 0.0025
630 BLOOD POTASSIUM DECREASED 76 0.0025
631 COAGULOPATHY 42 0.0025
632 TEMPERATURE INTOLERANCE 26 0.0025
633 MASS 35 0.0025
634 TOOTH INFECTION 33 0.0025
635 TINNITUS 115 0.0025
636 CHEST DISCOMFORT 256 0.0025
637 POST PROCEDURAL COMPLICATION 48 0.0025
638 DRUG TOXICITY 34 0.0025
639 CYANOSIS 39 0.0025
640 EMPHYSEMA 25 0.0025
641 DIZZINESS POSTURAL 24 0.0025
642 ANAEMIA 466 0.0024
643 BLOOD BILIRUBIN INCREASED 66 0.0024
644 DENTAL CARIES 27 0.0024
645 COLD SWEAT 43 0.0024
646 ANHEDONIA 64 0.0024
647 DIPLOPIA 63 0.0024
648 POOR VENOUS ACCESS 25 0.0024
649 HYPOXIA 85 0.0024
650 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 486 0.0024
651 PNEUMONIA BACTERIAL 22 0.0024
652 PETECHIAE 25 0.0024
653 INTERSTITIAL LUNG DISEASE 116 0.0024
654 SKIN DISCOLOURATION 110 0.0024
655 EXPIRED PRODUCT ADMINISTERED 79 0.0024
656 CELLULITIS 119 0.0024
657 HYPOTENSION 472 0.0024
658 MYOCLONUS 28 0.0023
659 BURNING SENSATION 164 0.0023
660 SKIN DISORDER 78 0.0023
661 EAR DISCOMFORT 24 0.0023
662 CYST 29 0.0023
663 SINUS TACHYCARDIA 33 0.0023
664 HYPOAESTHESIA ORAL 35 0.0023
665 VASCULITIS 27 0.0023
666 DECREASED ACTIVITY 25 0.0023
667 INTESTINAL PERFORATION 26 0.0023
668 SUICIDE ATTEMPT 140 0.0023
669 SPINAL FRACTURE 46 0.0023
670 COORDINATION ABNORMAL 32 0.0023
671 PARAESTHESIA ORAL 33 0.0023
672 HERPES ZOSTER 131 0.0023
673 PNEUMONITIS 62 0.0023
674 CARDIOMEGALY 28 0.0023
675 CHOLECYSTECTOMY 26 0.0023
676 URINARY TRACT INFECTION 387 0.0023
677 LYMPHADENOPATHY 80 0.0023
678 HAEMOPTYSIS 63 0.0023
679 TOOTH EXTRACTION 28 0.0022
680 NERVE INJURY 25 0.0022
681 SEROTONIN SYNDROME 43 0.0022
682 CARDIOGENIC SHOCK 32 0.0022
683 PRODUCT ADMINISTRATION ERROR 45 0.0022
684 SINUS DISORDER 44 0.0022
685 PRODUCT USE COMPLAINT 35 0.0022
686 PRURITUS GENERALISED 48 0.0022
687 OROPHARYNGEAL PAIN 205 0.0022
688 LYMPHOCYTE COUNT DECREASED 39 0.0022
689 APPLICATION SITE PRURITUS 50 0.0022
690 RASH MACULO-PAPULAR 49 0.0022
691 SWELLING FACE 143 0.0022
692 URINARY INCONTINENCE 65 0.0022
693 LACTIC ACIDOSIS 71 0.0022
694 HYPOTHYROIDISM 70 0.0022
695 LETHARGY 126 0.0022
696 SOPOR 29 0.0022
697 MYDRIASIS 28 0.0022
698 RHABDOMYOLYSIS 91 0.0022
699 RHINORRHOEA 141 0.0022
700 DRUG LEVEL INCREASED 36 0.0022
701 APPLICATION SITE ERYTHEMA 57 0.0022
702 ACUTE MYOCARDIAL INFARCTION 64 0.0022
703 CEREBRAL INFARCTION 53 0.0022
704 SURGERY 127 0.0022
705 VERTIGO 132 0.0022
706 PARALYSIS 31 0.0022
707 PROTEINURIA 41 0.0022
708 INTESTINAL OBSTRUCTION 81 0.0021
709 BRAIN OEDEMA 27 0.0021
710 TENDONITIS 33 0.0021
711 MUSCLE ATROPHY 27 0.0021
712 ABSCESS 34 0.0021
713 OCULAR HYPERAEMIA 101 0.0021
714 APATHY 31 0.0021
715 MYALGIA 361 0.0021
716 DEHYDRATION 283 0.0021
717 SMALL INTESTINAL OBSTRUCTION 26 0.0021
718 INTENTIONAL OVERDOSE 135 0.0021
719 INTENTIONAL DOSE OMISSION 60 0.0021
720 CONJUNCTIVITIS 39 0.0021
721 OXYGEN SATURATION DECREASED 118 0.0021
722 PRODUCT PRESCRIBING ERROR 50 0.0021
723 DIABETES MELLITUS 160 0.0021
724 PRODUCT COMPLAINT 53 0.0021
725 CARDIOVASCULAR DISORDER 53 0.0021
726 HEAD INJURY 66 0.0021
727 SOMNOLENCE 419 0.0021
728 EYE SWELLING 77 0.0021
729 OBSTRUCTIVE AIRWAYS DISORDER 23 0.0021
730 FEMUR FRACTURE 64 0.0021
731 CAESAREAN SECTION 24 0.0021
732 UPPER LIMB FRACTURE 41 0.0021
733 COLITIS 78 0.0021
734 BEDRIDDEN 27 0.0021
735 ACCIDENTAL OVERDOSE 75 0.0020
736 DEPRESSED LEVEL OF CONSCIOUSNESS 81 0.0020
737 BLOOD CALCIUM DECREASED 23 0.0020
738 TOOTHACHE 37 0.0020
739 INTERNATIONAL NORMALISED RATIO INCREASED 58 0.0020
740 LIVER FUNCTION TEST ABNORMAL 59 0.0020
741 ACUTE RESPIRATORY FAILURE 39 0.0020
742 BACTERAEMIA 24 0.0020
743 DIVERTICULITIS 56 0.0020
744 SYNCOPE 202 0.0020
745 BRADYCARDIA 107 0.0020
746 PHARYNGEAL OEDEMA 31 0.0020
747 PALPITATIONS 236 0.0020
748 HAEMATURIA 69 0.0020
749 FUNGAL INFECTION 67 0.0020
750 DRY EYE 100 0.0020
751 EYE IRRITATION 115 0.0020
752 HEART RATE IRREGULAR 45 0.0020
753 AGRANULOCYTOSIS 37 0.0020
754 BALANCE DISORDER 172 0.0020
755 PERICARDIAL EFFUSION 46 0.0020
756 TOOTH DISORDER 44 0.0020
757 INSURANCE ISSUE 30 0.0020
758 RESPIRATORY TRACT CONGESTION 31 0.0019
759 HAEMORRHOIDS 38 0.0019
760 SEPSIS 217 0.0019
761 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
762 DYSARTHRIA 73 0.0019
763 MYELODYSPLASTIC SYNDROME 28 0.0019
764 CATARACT 115 0.0019
765 BACTERIAL INFECTION 36 0.0019
766 HYPOKINESIA 28 0.0019
767 ORAL PAIN 43 0.0019
768 HYPERSOMNIA 55 0.0019
769 MUSCLE TWITCHING 44 0.0019
770 SKIN FISSURES 37 0.0019
771 HEMIPARESIS 32 0.0019
772 TRANSAMINASES INCREASED 42 0.0019
773 NO THERAPEUTIC RESPONSE 23 0.0019
774 THROAT TIGHTNESS 51 0.0019
775 RESPIRATORY DEPRESSION 23 0.0019
776 SPINAL OPERATION 23 0.0019
777 RESPIRATORY FAILURE 136 0.0019
778 BONE PAIN 109 0.0019
779 BASAL CELL CARCINOMA 29 0.0019
780 LACRIMATION INCREASED 56 0.0019
781 ANGINA PECTORIS 53 0.0018
782 VISION BLURRED 253 0.0018
783 INFLUENZA 205 0.0018
784 POLYNEUROPATHY 22 0.0018
785 PREMATURE BABY 55 0.0018
786 HEART RATE INCREASED 181 0.0018
787 COUGH 506 0.0018
788 VIRAL INFECTION 60 0.0018
789 HEART RATE DECREASED 63 0.0018
790 ORAL HERPES 35 0.0018
791 ENCEPHALOPATHY 44 0.0018
792 DEVICE MALFUNCTION 125 0.0018
793 DYSPHAGIA 168 0.0018
794 PRESYNCOPE 43 0.0018
795 NEUROPATHY PERIPHERAL 168 0.0018
796 GLAUCOMA 34 0.0018
797 MULTIPLE FRACTURES 29 0.0018
798 EYE DISORDER 58 0.0018
799 DIALYSIS 25 0.0018
800 PNEUMONIA ASPIRATION 44 0.0018
801 RENAL DISORDER 82 0.0018
802 APHASIA 53 0.0018
803 DEEP VEIN THROMBOSIS 114 0.0018
804 PULMONARY MASS 26 0.0017
805 LUNG INFECTION 27 0.0017
806 PANCREATITIS ACUTE 39 0.0017
807 CHILLS 202 0.0017
808 ORTHOSTATIC HYPOTENSION 30 0.0017
809 RESTLESSNESS 63 0.0017
810 THERAPEUTIC RESPONSE SHORTENED 57 0.0017
811 DERMATITIS 36 0.0017
812 ERECTILE DYSFUNCTION 44 0.0017
813 PNEUMOTHORAX 27 0.0017
814 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
815 DISTURBANCE IN ATTENTION 91 0.0017
816 FEELING ABNORMAL 403 0.0017
817 FEELING JITTERY 32 0.0017
818 POLLAKIURIA 70 0.0017
819 DELUSION 26 0.0017
820 HOT FLUSH 126 0.0017
821 IMMUNE SYSTEM DISORDER 22 0.0017
822 PRODUCT DOSE OMISSION ISSUE 490 0.0017
823 COVID-19 292 0.0017
824 HEPATOTOXICITY 37 0.0017
825 HAEMATOMA 43 0.0017
826 RASH MACULAR 58 0.0017
827 HYPERTHYROIDISM 24 0.0017
828 CARDIAC FAILURE 133 0.0017
829 EOSINOPHILIA 29 0.0017
830 WHITE BLOOD CELL COUNT DECREASED 179 0.0016
831 PELVIC PAIN 30 0.0016
832 MENTAL IMPAIRMENT 40 0.0016
833 THROAT IRRITATION 74 0.0016
834 EYE HAEMORRHAGE 22 0.0016
835 ARRHYTHMIA 78 0.0016
836 MUCOSAL INFLAMMATION 43 0.0016
837 SPEECH DISORDER 86 0.0016
838 DISEASE RECURRENCE 78 0.0016
839 HALLUCINATION, AUDITORY 26 0.0016
840 SKIN EXFOLIATION 138 0.0016
841 PHOTOSENSITIVITY REACTION 27 0.0016
842 RESPIRATORY ARREST 45 0.0016
843 PULMONARY OEDEMA 73 0.0016
844 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 85 0.0016
845 HEPATIC FAILURE 49 0.0016
846 PANIC ATTACK 59 0.0016
847 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
848 TREMOR 268 0.0016
849 HALLUCINATION, VISUAL 34 0.0016
850 PULMONARY EMBOLISM 153 0.0016
851 FLATULENCE 91 0.0016
852 ATRIAL FIBRILLATION 156 0.0016
853 CONVULSION 91 0.0016
854 DYSPHONIA 93 0.0016
855 PRODUCT DOSE OMISSION IN ERROR 45 0.0016
856 CHOKING 31 0.0016
857 ORAL DISCOMFORT 22 0.0016
858 FEELING COLD 44 0.0016
859 NERVOUS SYSTEM DISORDER 49 0.0016
860 BONE DENSITY DECREASED 49 0.0016
861 HIP FRACTURE 50 0.0016
862 EPISTAXIS 116 0.0015
863 MALIGNANT NEOPLASM PROGRESSION 158 0.0015
864 CANDIDA INFECTION 26 0.0015
865 FULL BLOOD COUNT DECREASED 31 0.0015
866 FRACTURE 29 0.0015
867 NEUTROPHIL COUNT DECREASED 62 0.0015
868 PULMONARY ARTERIAL HYPERTENSION 22 0.0015
869 BLOOD PRESSURE ABNORMAL 30 0.0015
870 RASH GENERALISED 39 0.0015
871 HAEMORRHAGE 156 0.0015
872 DYSKINESIA 60 0.0015
873 VISUAL ACUITY REDUCED 49 0.0015
874 HALLUCINATION 111 0.0015
875 BLOOD TRIGLYCERIDES INCREASED 26 0.0015
876 INJECTION SITE WARMTH 30 0.0015
877 EYE PRURITUS 49 0.0015
878 PRODUCT AVAILABILITY ISSUE 33 0.0014
879 COGNITIVE DISORDER 67 0.0014
880 ECZEMA 75 0.0014
881 CARDIAC ARREST 118 0.0014
882 MUSCLE TIGHTNESS 23 0.0014
883 BLOOD PRESSURE FLUCTUATION 34 0.0014
884 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
885 CHOLESTASIS 27 0.0014
886 MENTAL DISORDER 61 0.0014
887 SUICIDAL IDEATION 128 0.0014
888 PLATELET COUNT DECREASED 149 0.0014
889 IRRITABILITY 84 0.0014
890 PANCYTOPENIA 78 0.0014
891 THROMBOSIS 112 0.0014
892 HYPOGLYCAEMIA 67 0.0014
893 ABASIA 34 0.0014
894 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
895 AGEUSIA 34 0.0014
896 ACUTE RESPIRATORY DISTRESS SYNDROME 24 0.0014
897 INCORRECT DOSE ADMINISTERED 305 0.0013
898 METASTASES TO LIVER 23 0.0013
899 HERNIA 25 0.0013
900 DRUG RESISTANCE 33 0.0013
901 OSTEONECROSIS 42 0.0013
902 EXPOSURE VIA SKIN CONTACT 33 0.0013
903 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
904 FLUSHING 129 0.0013
905 UNEVALUABLE EVENT 96 0.0013
906 RESPIRATORY DISTRESS 35 0.0013
907 MOOD SWINGS 40 0.0013
908 HYPOACUSIS 54 0.0013
909 AGITATION 92 0.0013
910 MOOD ALTERED 34 0.0012
911 WITHDRAWAL SYNDROME 52 0.0012
912 DEPRESSED MOOD 65 0.0012
913 DYSGEUSIA 91 0.0012
914 MYOCARDIAL INFARCTION 210 0.0012
915 UNRESPONSIVE TO STIMULI 31 0.0012
916 NO ADVERSE EVENT 216 0.0012
917 INJECTION SITE BRUISING 95 0.0012
918 INFLUENZA LIKE ILLNESS 97 0.0012
919 EMOTIONAL DISTRESS 140 0.0012
920 MENTAL STATUS CHANGES 32 0.0012
921 CEREBRAL HAEMORRHAGE 41 0.0011
922 DISEASE PROGRESSION 135 0.0011
923 BONE MARROW FAILURE 23 0.0011
924 ASCITES 33 0.0011
925 PROCEDURAL PAIN 31 0.0011
926 SKIN CANCER 24 0.0011
927 ELECTROCARDIOGRAM QT PROLONGED 40 0.0011
928 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
929 COMA 52 0.0011
930 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
931 PAIN OF SKIN 29 0.0011
932 NERVOUSNESS 56 0.0011
933 SKIN IRRITATION 49 0.0011
934 SEIZURE 121 0.0010
935 INJECTION SITE SWELLING 80 0.0010
936 TOXICITY TO VARIOUS AGENTS 176 0.0010
937 HYPERGLYCAEMIA 38 0.0010
938 FEAR 28 0.0010
939 CARDIAC DISORDER 96 0.0010
940 MULTIPLE SCLEROSIS 49 0.0010
941 PSYCHOTIC DISORDER 30 0.0010
942 BLINDNESS 41 0.0010
943 INJECTION SITE PRURITUS 67 0.0010
944 NEEDLE ISSUE 29 0.0010
945 SKIN BURNING SENSATION 71 0.0010
946 INJECTION SITE ERYTHEMA 120 0.0010
947 DRUG EFFECT INCOMPLETE 35 0.0010
948 DRUG ABUSE 79 0.0009
949 INJECTION SITE MASS 35 0.0009
950 ACCIDENTAL EXPOSURE TO PRODUCT 97 0.0009
951 DEMENTIA 26 0.0009
952 OSTEONECROSIS OF JAW 23 0.0009
953 NEOPLASM PROGRESSION 32 0.0009
954 ANGER 31 0.0009
955 EMOTIONAL DISORDER 28 0.0009
956 ABNORMAL DREAMS 25 0.0009
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 63 0.0009
958 CRYING 32 0.0009
959 CEREBROVASCULAR ACCIDENT 149 0.0009
960 CARDIAC FAILURE CONGESTIVE 69 0.0009
961 DRY SKIN 114 0.0009
962 VAGINAL HAEMORRHAGE 37 0.0009
963 PRODUCT SUBSTITUTION ISSUE 48 0.0008
964 AGGRESSION 41 0.0008
965 INJECTION SITE PAIN 250 0.0008
966 THERAPY INTERRUPTED 58 0.0008
967 NEOPLASM MALIGNANT 53 0.0008
968 CARDIO-RESPIRATORY ARREST 33 0.0008
969 PRODUCT DOSE OMISSION 51 0.0008
970 FEBRILE NEUTROPENIA 51 0.0008
971 DEVICE LEAKAGE 33 0.0008
972 BLOOD GLUCOSE INCREASED 143 0.0008
973 LUNG NEOPLASM MALIGNANT 31 0.0008
974 DEVICE ISSUE 67 0.0007
975 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
976 DEATH 636 0.0007
977 DERMATITIS ATOPIC 38 0.0007
978 NEUTROPENIA 91 0.0007
979 ABNORMAL BEHAVIOUR 26 0.0007
980 INJECTION SITE HAEMORRHAGE 52 0.0007
981 DRUG EFFECT DECREASED 35 0.0006
982 MULTIPLE SCLEROSIS RELAPSE 43 0.0006
983 ABORTION SPONTANEOUS 25 0.0006
984 BLOOD GLUCOSE DECREASED 29 0.0006
985 BREAST CANCER 56 0.0006
986 PROSTATE CANCER 47 0.0006
987 COMPLETED SUICIDE 46 0.0006
988 DRUG WITHDRAWAL SYNDROME 45 0.0005
989 THERAPY CESSATION 23 0.0004
990 PRODUCT STORAGE ERROR 36 0.0004
991 DRUG DEPENDENCE 58 0.0004
992 DRUG DOSE OMISSION 54 0.0003
993 ACNE 24 0.0003